Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.66 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.65 |
| ▸ | FLT4 | P35916 | 1/20 | 0.65 |
| ▸ | GSK3B | P49841 | 1/20 | 0.65 |
| ▸ | RARB | P10826 | 1/20 | 0.65 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 4/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | XBP1 | P17861 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.59 |
| ▸ | RELA | Q04206 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13315750 | 0.88 | EPHA2 (0.63) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL501152 | 0.88 | EPHA2 (0.63) | KMT2AEPHA2FLT4GSK3BRARB | |
| Fluoride SCHEMBL5143071 | 0.86 | EPHA2 (0.61) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL10412645 | 0.86 | EPHA2 (0.61) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL14143563 | 0.85 | EPHA2 (0.60) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL13581391 | 0.85 | EPHA2 (0.60) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL5143074 | 0.85 | EPHA2 (0.60) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL12665479 | 0.85 | EPHA2 (0.60) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL12673580 | 0.85 | EPHA2 (0.60) | KMT2AEPHA2FLT4GSK3BRARB | |
| SCHEMBL7235269 | 0.85 | EPHA2 (0.59) | KMT2AEPHA2FLT4GSK3BRARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572657-B1 | PROCESSES FOR PREPARING QUINOLONECARBOXYLATE DERIVATIVES | YUHAN CORP (KR) | 2007-07-11 | — | — | EP | disclosed |
| US-7012144-B2 | Quinolone carboxylic acid derivatives | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2006-03-14 | — | — | US | disclosed |
| EP-1572657-A4 | PROCESSES FOR PREPARING QUINOLONECARBOXYLATE DERIVATIVES | YUHAN CORP (KR) | 2006-03-01 | — | — | EP | disclosed |
| EP-1572657-A1 | PROCESSES FOR PREPARING QUINOLONECARBOXYLATE DERIVATIVES | Yuhan Corporation (KR) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004056781-A1 | PROCESSES FOR PREPARING QUINOLONECARBOXYLATE DERIVATIVES | YUHAN CORPORATION (KR) | 2004-07-08 | — | — | WO | disclosed |
| US-20030130302-A1 | Quinolone carboxylic acid derivatives | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2003-07-10 | — | — | US | disclosed |
| US-5962468-A | ANTIBACTERIAL ACTIVITY | LG CHEMICAL LTD. (KR) | 1999-10-05 | — | — | US | disclosed |
| EP-0688772-B1 | Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation | LG CHEMICAL LTD (KR) | 1999-05-06 | — | — | EP | disclosed |
| US-5869670-A | BACTERICIDES | LG CHEMICAL LTD. (KR) | 1999-02-09 | — | — | US | disclosed |
| US-5840916-A | INTERMEDIATE FOR QUINOLONE ANTIBIOTICS; 4-AMINOMETHYL-3-METHOXYIMINOPYRROLIDINE | LG CHEMICAL LTD. (KR) | 1998-11-24 | — | — | US | disclosed |
| US-5776944-A | 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof | LG CHEMICAL LTD. (KR) | 1998-07-07 | — | — | US | disclosed |
| US-5698570-A | QUINOLONE ANTIBIOTIC; BACTERICIDES | LG CHEMICAL LTD. (KR) | 1997-12-16 | — | — | US | disclosed |
| US-5633262-A | BACTERICIDES | LG CHEMICAL LTD. (KR) | 1997-05-27 | — | — | US | disclosed |
| EP-0688772-A1 | Novel quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituents and processes for their preparation | LG Chemical Limited (KR) | 1995-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130302-A1 | Quinolone carboxylic acid derivatives | CYCS, CBR3, HCCS | KMT2A 2263/4885EPHA2 3440/4885FLT4 3592/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.